Prostate Cancer - Results from #140

Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography. December 10, 2021

The Use of High-Intensity Focused Ultrasound (HIFU) Plus 150mg Bicalutamide as First Line Salvage Therapy for Local Recurrent Prostate Cancer. December 10, 2021

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection. December 10, 2021

The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer. December 9, 2021

Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study. December 9, 2021

Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy. December 9, 2021

Comparison of Surgical or Medical Castration-Related Cardiotoxicity in Patients With Prostate Cancer. December 9, 2021

Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging. December 8, 2021

Inherited TP53 Variants and Risk of Prostate Cancer. December 8, 2021

Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300. December 8, 2021

Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA. December 8, 2021

Prostate cancer risk stratification via non-destructive 3D pathology with deep learning-assisted gland analysis. December 8, 2021

Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results From the Canary PASS Cohort. December 7, 2021

MRI-guided Biopsy in Active Surveillance of Prostate Cancer. December 7, 2021

Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. December 7, 2021

Setting up the Prostate Cancer Outcomes Registry of New Zealand: reflecting and influencing clinical practice. December 7, 2021

A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study Protocol. December 7, 2021

Delayed radical prostatectomy after a period of active surveillance is not associated with the use of secondary treatments compared with immediate prostatectomy. December 6, 2021

Useful predictors of progression-free survival for Japanese patients with LATITUDE-high-risk metastatic castration-sensitive prostate cancer who received upfront abiraterone acetate. December 6, 2021

Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer. December 6, 2021

Page 8 of 1198

email news signup